Synergistic Malaria Parasite Killing by Two Types of Plasmodial Surface Anion Channel Inhibitors

Malaria parasites increase their host erythrocyte's permeability to a broad range of ions and organic solutes. The plasmodial surface anion channel (PSAC) mediates this uptake and is an established drug target. Development of therapies targeting this channel is limited by several problems inclu...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 11; no. 2; p. e0149214
Main Authors Pain, Margaret, Fuller, Alexandra W, Basore, Katherine, Pillai, Ajay D, Solomon, Tsione, Bokhari, Abdullah A B, Desai, Sanjay A
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 11.02.2016
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Malaria parasites increase their host erythrocyte's permeability to a broad range of ions and organic solutes. The plasmodial surface anion channel (PSAC) mediates this uptake and is an established drug target. Development of therapies targeting this channel is limited by several problems including interactions between known inhibitors and permeating solutes that lead to incomplete channel block. Here, we designed and executed a high-throughput screen to identify a novel class of PSAC inhibitors that overcome this solute-inhibitor interaction. These new inhibitors differ from existing blockers and have distinct effects on channel-mediated transport, supporting a model of two separate routes for solute permeation though PSAC. Combinations of inhibitors specific for the two routes had strong synergistic action against in vitro parasite propagation, whereas combinations acting on a single route produced only additive effects. The magnitude of synergism depended on external nutrient concentrations, consistent with an essential role of the channel in parasite nutrient acquisition. The identified inhibitors will enable a better understanding of the channel's structure-function and may be starting points for novel combination therapies that produce synergistic parasite killing.
Bibliography:Conceived and designed the experiments: MP AWF KB ADP TS AABB SAD. Performed the experiments: MP AWF KB ADP TS AABB SAD. Analyzed the data: MP AWF KB ADP TS AABB SAD. Wrote the paper: MP AWF KB ADP TS AABB SAD.
Competing Interests: The authors of this manuscript have the following competing interests: SAD and ADP are named inventors on US and international patent applications and an issued US patent describing compounds presented in this manuscript (“INHIBITORS OF THE PLASMODIAL SURFACE ANION CHANNEL AS ANTIMALARIALS”, International Patent Application Publication WO/2010/011537; Chinese Patent Application 200980137435; European Patent Application EP2313100A1; Indian Patent Application 470/CHENP/2011; US Patent Application Publication US2014/0088082A1; and issued US Patent US8,618,090). There are no other patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0149214